Cairo - Mubasher: The listing committee of the Egyptian Exchange (EGX) decided to cancel the listing of DBK Pharmaceutical CO.
EGX noted that DBK's data will erased from the bourse's trading date base, as of Thursday 24 December.
Last August, the drug firm said it will delay its IPO due to the sell-off in the Egyptian market.
